Cargando…

Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba

Individuals with cancer are vulnerable to infection with SARS-CoV-2, the virus causing COVID-19. Physical distancing, the reallocation of health care resources, and the implementation of procedures to reduce the spread of COVID-19 may also have serious consequences for people with cancer. We evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Decker, Kathleen M., Lambert, Pascal, Feely, Allison, Bucher, Oliver, Kim, Julian O., Hebbard, Pamela, Thiessen, Maclean, Fatoye, Tunji, Pitz, Marshall, Koul, Rashmi, Czaykowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395519/
https://www.ncbi.nlm.nih.gov/pubmed/34436035
http://dx.doi.org/10.3390/curroncol28040269
_version_ 1783744192013402112
author Decker, Kathleen M.
Lambert, Pascal
Feely, Allison
Bucher, Oliver
Kim, Julian O.
Hebbard, Pamela
Thiessen, Maclean
Fatoye, Tunji
Pitz, Marshall
Koul, Rashmi
Czaykowski, Piotr
author_facet Decker, Kathleen M.
Lambert, Pascal
Feely, Allison
Bucher, Oliver
Kim, Julian O.
Hebbard, Pamela
Thiessen, Maclean
Fatoye, Tunji
Pitz, Marshall
Koul, Rashmi
Czaykowski, Piotr
author_sort Decker, Kathleen M.
collection PubMed
description Individuals with cancer are vulnerable to infection with SARS-CoV-2, the virus causing COVID-19. Physical distancing, the reallocation of health care resources, and the implementation of procedures to reduce the spread of COVID-19 may also have serious consequences for people with cancer. We evaluated the impact of COVID-19 on new cancer diagnoses and oncology care in Manitoba, Canada using an interrupted time series design and data from the Manitoba Cancer Registry and CancerCare Manitoba’s (CCMB) electronic medical record. In April 2020, there was a 23% decrease in new cancer diagnoses, a 21% decrease in pathology reports, and a 43% reduction in surgical resections. There was no difference in new cancer diagnoses by August 2020, surgery by July 2020, and pathology reports by September 2020. From April 2020 to June 2021, there was a 13% decrease in radiotherapy (RT) fractions, an 18% decrease in UCC visits, and a 52% decrease in in-person visits. There was no change in intravenous chemotherapy visits per month, first RT visits, or overall patient visits. The impact of COVID-19 on shifts in the stage at diagnosis and survival will be assessed in future analyses.
format Online
Article
Text
id pubmed-8395519
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83955192021-08-28 Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba Decker, Kathleen M. Lambert, Pascal Feely, Allison Bucher, Oliver Kim, Julian O. Hebbard, Pamela Thiessen, Maclean Fatoye, Tunji Pitz, Marshall Koul, Rashmi Czaykowski, Piotr Curr Oncol Article Individuals with cancer are vulnerable to infection with SARS-CoV-2, the virus causing COVID-19. Physical distancing, the reallocation of health care resources, and the implementation of procedures to reduce the spread of COVID-19 may also have serious consequences for people with cancer. We evaluated the impact of COVID-19 on new cancer diagnoses and oncology care in Manitoba, Canada using an interrupted time series design and data from the Manitoba Cancer Registry and CancerCare Manitoba’s (CCMB) electronic medical record. In April 2020, there was a 23% decrease in new cancer diagnoses, a 21% decrease in pathology reports, and a 43% reduction in surgical resections. There was no difference in new cancer diagnoses by August 2020, surgery by July 2020, and pathology reports by September 2020. From April 2020 to June 2021, there was a 13% decrease in radiotherapy (RT) fractions, an 18% decrease in UCC visits, and a 52% decrease in in-person visits. There was no change in intravenous chemotherapy visits per month, first RT visits, or overall patient visits. The impact of COVID-19 on shifts in the stage at diagnosis and survival will be assessed in future analyses. MDPI 2021-08-12 /pmc/articles/PMC8395519/ /pubmed/34436035 http://dx.doi.org/10.3390/curroncol28040269 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Decker, Kathleen M.
Lambert, Pascal
Feely, Allison
Bucher, Oliver
Kim, Julian O.
Hebbard, Pamela
Thiessen, Maclean
Fatoye, Tunji
Pitz, Marshall
Koul, Rashmi
Czaykowski, Piotr
Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba
title Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba
title_full Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba
title_fullStr Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba
title_full_unstemmed Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba
title_short Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba
title_sort evaluating the impact of the covid-19 pandemic on new cancer diagnoses and oncology care in manitoba
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395519/
https://www.ncbi.nlm.nih.gov/pubmed/34436035
http://dx.doi.org/10.3390/curroncol28040269
work_keys_str_mv AT deckerkathleenm evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT lambertpascal evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT feelyallison evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT bucheroliver evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT kimjuliano evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT hebbardpamela evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT thiessenmaclean evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT fatoyetunji evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT pitzmarshall evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT koulrashmi evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba
AT czaykowskipiotr evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba